Comparison of methodologies to define hemodialysis patients hyporesponsive to epoetin and impact on counts and characteristics

Keyphrases

• African American 16%
• African Patient 16%
• Anemia 16%
• Cardiac Disease 16%
• Comorbid Conditions 50%
• Comorbidity Burden 16%
• Congestive Heart Failure 16%
• Diabetes 16%
• Dialysis Duration 16%
• Epoetin Alfa 100%
• Erythropoiesis-stimulating Agents 33%
• Erythropoietin 66%
• Erythropoietin Hyporesponsiveness 16%
• Gastrointestinal Bleeding 33%
• Gastrointestinal Cancer 33%
• Hemodialysis Patients 100%
• Hemoglobin Level 16%
• High Dose 16%
• Hypertension 16%
• Hyporesponsive 100%
• Hyporesponsiveness 100%
• Long Dialysis 16%
• Medicare 16%
• National Cohort 16%
• Patient Characteristics 16%
• Peripheral Vascular Disease 16%
• Primary Payer 16%
• Renal Failure 16%
• RhEPO 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Anemia 20%
• Antianemic Agent 40%
• Comorbidity 20%
• Congestive Heart Failure 20%
• Digestive System Cancer 40%
• Erythropoietin 100%
• Gastrointestinal Hemorrhage 40%
• Heart Disease 20%
• Hemodialysis 100%
• Kidney Failure 20%
• Peripheral Vascular Disease 20%
• Recombinant Erythropoietin 100%

Biochemistry, Genetics and Molecular Biology

• Comorbidity 20%
• Darbepoetin Alfa 20%
• Erythropoiesis-Stimulating Agent 40%
• Erythropoietin 100%
• Hemodialysis 100%
• Hemoglobin Blood Level 20%